These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31719130)

  • 21. Hepatitis delta virus.
    Hughes SA; Wedemeyer H; Harrison PM
    Lancet; 2011 Jul; 378(9785):73-85. PubMed ID: 21511329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis delta virus infection in French male HBsAg-positive homosexuals.
    Pol S; Dubois F; Roingeard P; Zignego L; Housset C; Brechot C; Goudeau A; Berthelot P
    Hepatology; 1989 Sep; 10(3):342-5. PubMed ID: 2668149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of delta infection in drug addicts in Valencia, Spain.
    Rodrigo JM; Serra MA; Gimeno V; Olmo JA; Aparisi L; Escudero A; Wassel AH; Bixquert M
    Prog Clin Biol Res; 1987; 234():407-8. PubMed ID: 3628399
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hepatitis D and Hepatitis E].
    Sakugawa H; Yamashiro T; Maeshiro T
    Nihon Naika Gakkai Zasshi; 2004 Nov; 93(11):2351-6. PubMed ID: 15624471
    [No Abstract]   [Full Text] [Related]  

  • 25. Hepatitis D diagnostics:Utilization and testing in the United States.
    Safaie P; Razeghi S; Rouster SD; Privitera I; Sherman KE
    Virus Res; 2018 May; 250():114-117. PubMed ID: 29596839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular epidemiology of hepatitis delta virus in the Western Pacific region.
    Han M; Littlejohn M; Yuen L; Edwards R; Devi U; Bowden S; Ning Q; Locarnini S; Jackson K
    J Clin Virol; 2014 Sep; 61(1):34-9. PubMed ID: 24973283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hepatitis delta (D) virus infection: general aspects of epidemiology, infection modes and clinical picture].
    Ogata N
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():406-11. PubMed ID: 15453356
    [No Abstract]   [Full Text] [Related]  

  • 28. Evolutionary trends in the prevalence of anti-HDV antibodies among patients positive for HBsAg referred to a national laboratory in Cameroon from 2012 to 2017.
    Noubissi-Jouegouo L; Atsama MA; Tagnouokam-Ngoupo PA; Monamele CG; Ngono L; Njouom R
    BMC Res Notes; 2019 Jul; 12(1):417. PubMed ID: 31307546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HDV: thirty years later.
    Smedile A; Rizzetto M
    Dig Liver Dis; 2011 Jan; 43 Suppl 1():S15-8. PubMed ID: 21195366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High prevalence of hepatitis delta virus infection detectable by enzyme immunoassay among apparently healthy individuals in Mongolia.
    Inoue J; Takahashi M; Nishizawa T; Narantuya L; Sakuma M; Kagawa Y; Shimosegawa T; Okamoto H
    J Med Virol; 2005 Jul; 76(3):333-40. PubMed ID: 15902700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Delta hepatitis virus (HDV) marker].
    Inoue O; Yano M
    Nihon Rinsho; 1999 Nov; 57 Suppl():356-8. PubMed ID: 10635856
    [No Abstract]   [Full Text] [Related]  

  • 32. Delta hepatitis in Kiribati: a pacific focus.
    Tibbs CJ
    J Med Virol; 1989 Oct; 29(2):130-2. PubMed ID: 2600590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delta infection in asymptomatic carriers of hepatitis B surface antigen: low prevalence of delta activity and effective suppression of hepatitis B virus replication.
    Chen PJ; Chen DS; Chen CR; Chen YY; Chen HM; Lai MY; Sung JL
    Hepatology; 1988; 8(5):1121-4. PubMed ID: 3417233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis D virus infection among hepatitis B virus surface antigen positive individuals in Upper Egypt: Prevalence and clinical features.
    Makhlouf NA; Morsy KH; Mahmoud AA
    J Infect Public Health; 2019; 12(3):350-356. PubMed ID: 30833193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of delta antigen/antibody in various HBsAg positive patients in Saudi Arabia.
    Shobokshi OA; Serebour FE
    Prog Clin Biol Res; 1987; 234():471-5. PubMed ID: 2819896
    [No Abstract]   [Full Text] [Related]  

  • 36. [Epidemiology of hepatitis D virus infection].
    Joller-Jemelka HI; Guggi T; Grob PJ
    Schweiz Med Wochenschr; 1985 Nov; 115(47):1679-84. PubMed ID: 4081699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of the hepatitis delta virus in Rumania.
    Tapalaga D; Forzani B; Hele C; Paravacini O; Ponzetto A; Theilmann L
    Hepatogastroenterology; 1986 Dec; 33(6):238-9. PubMed ID: 3804180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of anti-delta antibodies in selected populations of HBsAg carriers in the Białystok region, Poland.
    Boroń P; Boroń-Kaczmarska A; Bobrowska E; Kamińska H; Lapiński W
    Prog Clin Biol Res; 1987; 234():427. PubMed ID: 3628403
    [No Abstract]   [Full Text] [Related]  

  • 39. [Delta hepatitis].
    Rizzetto M; Verme G
    Internist (Berl); 1985 Oct; 26(10):628-32. PubMed ID: 3908367
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical significance of hepatitis delta virus marker analysis].
    Yotsumoto S; Omi S; Okada S; Okamoto H
    Nihon Rinsho; 1990 Feb; 48 Suppl():304-8. PubMed ID: 2355548
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.